NVS 241220 100.00C (NVS241220C100000) Stock Options, News & Quotes

US OptionsDetailed Quotes

NVS241220C100000

Watchlist

4.50
-0.11-2.39%

15min DelayTrading Nov 19 11:18 ET

4.50High4.50Low

Intraday

5D
Daily

News

Novartis Analyst Ratings
Benzinga12:39 ET · Ratings
Erste Group Downgrades Novartis AG(NVS.US) to Hold Rating
Moomoo NewsNov 19 08:31 ET · Ratings
Express News | Us CDC Says Since April Confirmed Avian Influenza A(H5) Virus Infections In 52 People In US; Aware Of Human Case Of H5N1 Bird Flu Reported In Canada & Is In Communication With Public Health Agency Of Canada
BenzingaNov 18 11:34 ET
Novartis Currently Down Seven Consecutive Days, on Track for Longest Losing Streak Since May 2023 -- Data Talk
Dow JonesNov 18 11:17 ET
Novartis Pharma, Ratio Therapeutics Collaborate to Develop Cancer Treatment Candidate
MT NewswiresNov 18 09:14 ET
Ratio Therapeutics Enters License And Collaboration Agreement With Novartis For SSTR2-Targeting Radiotherapeutic Candidate; Under The Terms Of The Agreement, Ratio Will Receive Combined Upfront And Potential Milestone Payments Up To $745M
BenzingaNov 18 08:04 ET

Comments

10xStockPicks

Nov 15 08:23

ESPR Will Propel Higher, Events This Weekend & Analyst Event Next Week, Stock Price

This $2 Stock Remains Deeply Undervalued, Profitable in 2025, Offers 10x Upside within 20 Months
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...

+18

thz stock ful of sht

Nov 15 01:20

DOWN

$Eli Lilly and Co (LLY.US)$ $Novo-Nordisk A/S (NVO.US)$ $Johnson & Johnson (JNJ.US)$ $AbbVie (ABBV.US)$ $Merck & Co (MRK.US)$ $ROCHE HOLDING AG (RHHBY.US)$ $Novartis AG (NVS.US)$ $AstraZeneca (AZN.US)$ $Amgen (AMGN.US)$ $Pfizer (PFE.US)$

10xStockPicks

Nov 8 08:28

This $2 Stock Remains Deeply Undervalued, Profitable in 2025, Offers 10x Upside within 20 Months

Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary...

+18

Asherboy88

Nov 5 09:58

$Novartis AG (NVS.US)$ Why it keeps dropping ? didn't see any bad news

Stock_Drift

Oct 18 05:56

$Novartis AG (NVS.US)$

Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer